Search Prime Grants

U01AG076805

Cooperative Agreement

Overview

Grant Description
Circuit-Specific Cell Types in Aging and Alzheimer's Disease - Abstract

The long-term goal of this project is to define and identify circuit-specific cell types - cellular scale connectome - that are selectively vulnerable to loss of cell bodies or axonal connections or change of transcriptomic signatures of individual neurons during the progression of healthy aging and Alzheimer's disease (AD). Evidence suggests that knowledge on the change of cellular scale connectomes - cell type-specific circuits by coupling single cell transcriptome with brain connectivity - is needed for holistic understanding of aging and AD and provides an experimentally tractable basis to address longitudinal changes. These aging- and AD-associated changes may include loss of cell types, connectivity or alterations in transcriptomic signatures.

This approach employed here is to test the hypothesis that there are aging- or AD state-specific neural and molecular circuits that drive the progression of aging and AD. A large body of evidence demonstrates that AD is a heterogeneous, multifactorial disease that selectively affects certain brain regions, e.g. the entorhinal cortex (EC), while other areas, such as the cerebellum, remain unaffected. Recent studies on the staging of AD neuropathology showed AD-related neuropathology begins in the locus coeruleus (LC) or the EC, followed by the hippocampus (HC) and then the prefrontal cortex (PFC). The LC contains both adrenergic (NA) and non-noradrenergic neurons and provides the major NA inputs throughout the entire brain. Neuropathological staging has shown that tangles first appear in the LC and NA activation has been shown to ameliorate AD deficits. The EC provides key cortical inputs to the HC, which is essential in learning memory. The PFC provides the top-down regulation on various higher order functions. But cell types-based input and/or output networks that are selectively vulnerable at the single neurons level are not well understood.

As aging is a major risk factor for AD, it is important to understand whether there are distinct, similar or overlapping selectively vulnerable circuit-specific cell types between aging and AD. This project is to combine retrograde labeling with multiomic sn-RNAseq and sn-ATACseq to link transcriptomic and epigenomic properties of cell types to neuronal projections and investigate circuit-specific changes associated with progression of aging and AD in four brain regions, namely the LC, EC, HC and PFC, in both male and female control and AD mice. For AD mice, the APPNL-F mouse line - that carries knockin human mutations in the amyloid precursor protein gene and, importantly, expresses physiological levels of Aβ, mimicking late onset AD - will be used. The data from this project will provide novel insights on the types of neurons vulnerable to degeneration and/or alterations of molecular/signaling signature networks in a spatial and temporal fashion and the correlation with neuropathology and cognitive impairment. This approach is a major step toward establishing multiscale models that will help to fill the gap between the effects of genetic variants (e.g., APP, APOE or TREM2) on brain topology with molecular networks in aging and AD.
Funding Goals
TO ENCOURAGE BIOMEDICAL, SOCIAL, AND BEHAVIORAL RESEARCH AND RESEARCH TRAINING DIRECTED TOWARD GREATER UNDERSTANDING OF THE AGING PROCESS AND THE DISEASES, SPECIAL PROBLEMS, AND NEEDS OF PEOPLE AS THEY AGE. THE NATIONAL INSTITUTE ON AGING HAS ESTABLISHED PROGRAMS TO PURSUE THESE GOALS. THE DIVISION OF AGING BIOLOGY EMPHASIZES UNDERSTANDING THE BASIC BIOLOGICAL PROCESSES OF AGING. THE DIVISION OF GERIATRICS AND CLINICAL GERONTOLOGY SUPPORTS RESEARCH TO IMPROVE THE ABILITIES OF HEALTH CARE PRACTITIONERS TO RESPOND TO THE DISEASES AND OTHER CLINICAL PROBLEMS OF OLDER PEOPLE. THE DIVISION OF BEHAVIORAL AND SOCIAL RESEARCH SUPPORTS RESEARCH THAT WILL LEAD TO GREATER UNDERSTANDING OF THE SOCIAL, CULTURAL, ECONOMIC AND PSYCHOLOGICAL FACTORS THAT AFFECT BOTH THE PROCESS OF GROWING OLD AND THE PLACE OF OLDER PEOPLE IN SOCIETY. THE DIVISION OF NEUROSCIENCE FOSTERS RESEARCH CONCERNED WITH THE AGE-RELATED CHANGES IN THE NERVOUS SYSTEM AS WELL AS THE RELATED SENSORY, PERCEPTUAL, AND COGNITIVE PROCESSES ASSOCIATED WITH AGING AND HAS A SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO EXPAND AND IMPROVE THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Place of Performance
La Jolla, California 92037 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 294% from $2,876,357 to $11,340,010.
San Diego, California Salk Institute For Biological Studies was awarded Circuit-specific cell types in aging and Alzheimer's disease Cooperative Agreement U01AG076805 worth $11,340,010 from National Institute on Aging in June 2022 with work to be completed primarily in La Jolla California United States. The grant has a duration of 5 years and was awarded through assistance program 93.866 Aging Research. The Cooperative Agreement was awarded through grant opportunity The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 6/5/25

Period of Performance
6/1/22
Start Date
5/31/27
End Date
67.0% Complete

Funding Split
$11.3M
Federal Obligation
$0.0
Non-Federal Obligation
$11.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01AG076805

Subgrant Awards

Disclosed subgrants for U01AG076805

Transaction History

Modifications to U01AG076805

Additional Detail

Award ID FAIN
U01AG076805
SAI Number
U01AG076805-3847990489
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
NNJ6BMBTFGN5
Awardee CAGE
6H867
Performance District
CA-50
Senators
Dianne Feinstein
Alejandro Padilla

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) Health research and training Grants, subsidies, and contributions (41.0) $5,720,884 100%
Modified: 6/5/25